Facebook
Twitter
Telegram
Report an ErrorEvoke Pharma Balance Sheet 2011-2024 | EVOK
Annual Balance Sheet Evoke Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -2.96 M | -5.53 M | -5.32 M | -7.68 M | -9.01 M | -4.31 M | -9.76 M | -21.2 M | 864 K | -866 K |
Long Term Debt |
- | - | - | 5 M | - | - | - | - | 4.23 M | 4.24 M | 1.51 M | 980 K | - |
Long Term Debt Current |
13.4 K | 129 K | 12.4 K | 142 K | 139 K | - | - | - | 146 K | 150 K | 1.44 M | - | - |
Total Non Current Liabilities |
6.61 M | 6.11 M | 5.61 M | 5.11 M | - | - | 3.7 M | 4.1 M | 4.23 M | 4.24 M | 1.52 M | 19.2 M | 18.2 M |
Total Current Liabilities |
9.65 M | 1.65 M | 1.41 M | 7.54 M | 2.02 M | 1.63 M | 2.07 M | 1.41 M | 1.83 M | 1.87 M | 2.28 M | - | - |
Total Liabilities |
9.65 M | 7.77 M | 7.02 M | 12.6 M | 2.02 M | 1.63 M | 5.78 M | 5.51 M | 6.07 M | 6.11 M | 3.8 M | 19.8 M | 18.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-123 M | -116 M | -107 M | -98.9 M | -85.7 M | -78.6 M | -71 M | -58.8 M | -48.1 M | -35.9 M | -22.7 M | -19.9 M | -17.8 M |
Total Assets |
7.07 M | 11.9 M | 10.6 M | 9.43 M | 6.4 M | 5.66 M | 7.94 M | 9.29 M | 9.53 M | 15.3 M | 25 M | 116 K | 905 K |
Cash and Cash Equivalents |
4.74 M | 9.84 M | 9.14 M | 8.07 M | 5.66 M | 5.32 M | 7.68 M | 9.01 M | 8.69 M | 14.2 M | 24.2 M | 116 K | - |
Book Value |
-2.58 M | 4.08 M | 3.56 M | -3.21 M | 4.38 M | 4.03 M | 2.17 M | 3.79 M | 3.46 M | 9.19 M | 21.2 M | -19.7 M | -17.7 M |
Total Shareholders Equity |
-2.58 M | 4.08 M | 3.56 M | -3.21 M | 4.38 M | 4.03 M | 2.17 M | 3.79 M | 3.46 M | 9.19 M | 21.2 M | -19.7 M | - |
All numbers in USD currency
Quarterly Balance Sheet Evoke Pharma
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | 13.4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.68 M | 4.23 M | 4.23 M | 4.23 M | 4.23 M | 4.2 M | 4.2 M | 4.2 M | 4.24 M | 1.51 M | 1.51 M | 1.51 M | 1.51 M | 980 K | 980 K | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 6.49 M | 6.36 M | 6.24 M | 6.11 M | 6 M | 5.86 M | 5.74 M | 5.61 M | 5.49 M | 5.36 M | 5.24 M | 5.11 M | 5.11 M | 5.11 M | 5.11 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
8.96 M | 9.65 M | 8.73 M | 8.44 M | 7.91 M | 7.77 M | 7.88 M | 7.21 M | 7.09 M | 7.02 M | 6.88 M | 11.6 M | 11.5 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 2.02 M | 2.02 M | 2.02 M | - | 1.63 M | 1.61 M | 1.27 M | 1.2 M | 5.78 M | 5.78 M | 5.78 M | 5.78 M | 5.51 M | 5.51 M | 5.51 M | 5.51 M | 6.07 M | 6.07 M | 6.07 M | 6.07 M | 6.04 M | 6.04 M | 6.04 M | 6.11 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 1.55 M | 1.55 M | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-125 M | -123 M | -121 M | -120 M | -118 M | -116 M | -114 M | -112 M | -110 M | -107 M | -106 M | -104 M | -101 M | -98.9 M | -98.9 M | -98.9 M | -98.9 M | -85.7 M | -85.7 M | -85.7 M | -85.7 M | -78.6 M | -78.6 M | -78.6 M | -78.6 M | -71 M | -71 M | -71 M | -71 M | -58.8 M | -58.8 M | -58.8 M | -58.8 M | -48.1 M | -48.1 M | -48.1 M | -48.1 M | -35.9 M | -35.9 M | -35.9 M | -35.9 M | -22.7 M | -22.7 M | -22.7 M | - | - | - | - | - | - | - | - | - |
Total Assets |
12.5 M | 7.07 M | 7.85 M | 8.98 M | 10 M | 11.9 M | 13.4 M | 14.4 M | 9.03 M | 10.6 M | 11.6 M | 17.6 M | 19.3 M | 9.43 M | 9.43 M | 9.43 M | 9.43 M | 6.4 M | 6.4 M | 6.4 M | 6.4 M | 5.66 M | 5.66 M | 5.66 M | 5.66 M | 7.94 M | 7.94 M | 7.94 M | 7.94 M | 9.29 M | 9.29 M | 9.29 M | 9.29 M | 9.53 M | 9.53 M | 9.53 M | 9.53 M | 15.2 M | 15.2 M | 15.2 M | 15.3 M | 25 M | 25 M | 25 M | 25 M | 116 K | 116 K | - | - | - | - | - | - |
Cash and Cash Equivalents |
9.7 M | 4.74 M | 5.96 M | 7.01 M | 8.21 M | 9.84 M | 12.4 M | 13.5 M | 7.7 M | 9.14 M | 11.1 M | 16.7 M | 18.2 M | 8.07 M | 8.07 M | 8.07 M | 8.07 M | 5.66 M | 5.66 M | 5.66 M | 5.66 M | 5.32 M | 5.32 M | 5.32 M | 5.32 M | 7.68 M | 7.68 M | 7.68 M | 7.68 M | 9.01 M | 9.01 M | 9.01 M | 9.01 M | 8.69 M | 8.69 M | 8.69 M | 8.69 M | 14.2 M | 14.2 M | 14.2 M | 14.2 M | 24.2 M | 24.2 M | 24.2 M | 24.2 M | 116 K | 116 K | - | - | 866 K | - | - | - |
Book Value |
3.5 M | -2.58 M | -874 K | 538 K | 2.13 M | 4.08 M | 5.53 M | 7.19 M | 1.93 M | 3.56 M | 4.77 M | 5.97 M | 7.81 M | -3.21 M | -3.21 M | -3.21 M | -3.21 M | 4.38 M | 4.38 M | 4.38 M | 6.4 M | 4.03 M | 4.05 M | 4.39 M | 4.46 M | 2.17 M | 2.17 M | 2.17 M | 2.17 M | 3.79 M | 3.79 M | 3.79 M | 3.79 M | 3.46 M | 3.46 M | 3.46 M | 3.46 M | 9.19 M | 9.19 M | 9.19 M | 9.19 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M | -1.43 M | -1.43 M | - | - | - | - | - | - |
Total Shareholders Equity |
3.5 M | -2.58 M | -874 K | 538 K | 2.13 M | 4.08 M | 5.53 M | 7.19 M | 1.93 M | 3.56 M | 4.77 M | 5.97 M | 7.81 M | -3.21 M | -3.21 M | -3.21 M | -3.21 M | 4.38 M | 4.38 M | 4.38 M | 4.38 M | 4.03 M | 4.03 M | 4.03 M | 4.03 M | 2.17 M | 2.17 M | 2.17 M | 2.17 M | 3.79 M | 3.79 M | 3.79 M | 3.79 M | 3.46 M | 3.46 M | 3.46 M | 3.46 M | 9.19 M | 9.19 M | 9.19 M | 9.19 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M | -19.7 M | -19.7 M | - | - | -17.7 M | - | - | - |
All numbers in USD currency